|
In vitro screening for the tumoricidal properties of international medicinal herbs |
80.00% |
|
In vitro induction of apoptotic cell death in chronic lymphocytic leukemia by two natural products: preliminary study |
70.00% |
|
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. |
90.00% |
|
Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma. |
100.00% |
|
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus. |
100.00% |
|
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort s |
|
|
Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer..... |
75.00% |
|
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled m |
80.00% |
|
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ |
90.00% |
|
Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto |
80.00% |
|
Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase. |
60.00% |
|
Immunomodulatory effects of opioids. |
90.00% |
|
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, |
50.00% |
|
Ifosfamide, carboplatin, and etoposide (ICE) in combination with regional hyperthermia (RHT) in chemotherapy-pretreated non..... |
40.00% |
|
Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosp |
50.00% |
|
Hypoxia-inducible factor-1alpha modulation in combination with anti-angiogenic therapy. |
60.00% |
|
Hypoxia in cancer: significance and impact on clinical outcome. |
70.00% |
|
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. |
80.00% |
|
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. |
90.00% |
|
Hyperthermia and Immunity. A Brief Overview |
70.00% |
|
Hyperthermia adds to chemotherapy. |
90.00% |
|
Hypericine |
83.33% |
|
Homeopatic therapy in Cancer Treatment |
|
|
Homeopathy as a supportive therapy in cancer. |
70.00% |
|
Holistisk Cancer Behandling och Cancer Psykoterapi Inspirerad av Dr. Fred B. Levenson |
100.00% |
|
Holistic Cancer Treatment and Psychotherapy inspired by Dr Fred B Levenson |
|
|
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer with metronomic UFT + CP |
60.00% |
|
High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomised study. |
80.00% |
|
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and re |
70.00% |
|
High Dose Intravenous Vitamin C |
10.00% |
|
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. |
95.00% |
|
Herbal Based Cancer Therapies |
10.00% |
|
Hepatocyte growth factor as inducer of gefitinib resistance in non-small cell lung cancer harboring EGFR activating mutations. |
40.00% |
|
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary |
60.00% |
|
Glioblastoma Multiforme |
50.00% |
|
Gemcitabine |
|
|
GcMAF-The cancer revolution from Japan |
87.50% |
|
Gastric cancer originating from bone marrow-derived cells. |
70.00% |
|
Garlic, or Allium sativum: a review of its potential use as an anti-cancer agent. |
70.00% |
|
Focal therapy for prostate cancer: revolution or evolution? |
60.00% |
|
Focal laser ablation of prostate cancer: definition, needs, and future |
70.00% |
|
Five novel mono-tetrahydrofuran ring acetogenins from the seeds of Annona muricata. |
50.00% |
|
Final results of a pharmacokinetic (PK) and pharmacodynamic (PD) phase I trial of ARQ 197 incorporating dynamic contrast........ |
60.00% |
|
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. |
50.00% |
|
Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells |
60.00% |
|
Experimental Radiology |
70.00% |
|
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. |
63.33% |
|
Evaluation of the treatment of peritoneal carcinomatosis of colorectal cancer (CRC) with complete cytoreduction and hyperthe.... |
80.00% |
|
Evaluation of recombinant bacillus Calmette-Guerin expressing pertussis toxin in bladder cancer. |
50.00% |
|
Evaluation of mutagenic, genotoxic and transforming properties of Ukrain |
|
|
Evaluation of anticancer activities of benzo phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line. |
80.00% |
|
Epidemiologic evidence on coffee and cancer. |
70.00% |
|
Ependymoma. |
40.00% |
|
Enzymatically Extracted Apple Pectin Possesses Antioxidant and Antitumor Activity |
100.00% |
|
Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual sta |
80.00% |
|
Enhancement of macrophage tumouricidal activity by the alkaloid derivative |
40.00% |
|
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy – case report and review of literat |
80.00% |
|
Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidine. |
60.00% |
|
Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata. |
70.00% |
|
Energy metabolism, proteotoxic stress and age-related dysfunction - protection by carnosine. |
70.00% |
|
Electromagnetic energy as a bridge between atomic and cellular levels in the genetics approach to cancer treatment. |
90.00% |
|
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal ca. patients |
70.00% |
|
Efficacy of ukrain in the treatment of pancreatic cancer. |
70.00% |
|
Efficacy of homeopathic therapy in cancer treatment |
90.00% |
|
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia. |
90.00% |
|
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocy.. |
80.00% |
|
Effects of opioids on the immune system. |
70.00% |
|
Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. |
50.00% |
|
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. |
70.00% |
|
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. |
90.00% |
|
Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regi |
80.00% |
|
Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice |
90.00% |
|
Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice. |
30.00% |
|
Effect of Ukrain on matrix metalloproteinase-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) expression in human.... |
80.00% |
|
Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro. |
|
|
Effect of some isoquinoline alkaloids on enzymatic activity of acetylcholinesterase and monoamine oxidase |
80.00% |
|
Effect of metronomic use of zoledronic acid (ZOL) on antitumor and antiosteoclastic effects in breast cancer patients with bone |
70.00% |
|
Effect of emodin combined gemcitabine on the growth and apoptosis of pancreatic cancer cell line BxPC-3 in vitro |
80.00% |
|
Effect of culture supernatant of Toxoplasma gondii on the proliferation and apoptosis of BGC-823 cells |
70.00% |
|
Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin.... |
50.00% |
|
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) stud |
|
|
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide r |
70.00% |
|
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate ca |
80.00% |
|
DR. MIKAEL NORDFORS INTERVIEWED BY SONIA POULTON 04.02.2022 |
80.00% |
|
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer. |
60.00% |
|
Dose-Dense and/or Metronomic Schedules of Specific Chemotherapies Consolidate the Chemosensitivity of Triple-Negative Breast Can |
63.33% |
|
Does the Ukrain preparation protect mice against lethal doses of bacteria? |
60.00% |
|
Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment? |
50.00% |
|
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a |
90.00% |
|
Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in |
80.00% |
|
Digitoxin and its analogs as novel cancer therapeutics. |
70.00% |
|
Different metronomic treatment schedules |
80.00% |
|
Die Rolle von Boswellia-Säuren in der Therapie maligner Gliome: Methodische Mängel |
50.00% |
|
Dichloroacetic acid |
90.00% |
|
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. |
95.00% |
|
Deuterium Depletion Inhibits Cell Proliferation, RNA and Nuclear Membrane Turnover to Enhance Survival in Pancreatic Cancer |
100.00% |
|
Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung. |
100.00% |
|
Dentists, dental nurses, and brain tumours |
|
|
Dendritic cell-based vaccination in combination with gemcitabine/S-1 in patients with advanced pancreatic cancer. Sub-category: |
90.00% |
|
Dendritic cell vaccination in melanoma patients: Update and subgroup analysis of clinical response to post-vaccine treatment. |
80.00% |
